Literature DB >> 17261579

Children with pneumonia: how do they present and how are they managed?

Julia E Clark1, Donna Hammal, David Spencer, Fiona Hampton.   

Abstract

OBJECTIVE: To describe the spectrum of clinical features and management of community acquired pneumonia in the UK.
DESIGN: Prospectively recorded clinical details for all children with possible pneumonia and chest x ray (CXR) changes in 13 hospitals in the North of England between 2001 and 2002.
RESULTS: 89% of 711 children presenting to hospital with pneumonia were admitted; 96% received antibiotics, 70% intravenously. 20% had lobar CXR changes, 3% empyema and 4% required intensive care. Respiratory rate (RR), hypoxia and dyspnoea all correlated with each other and prompted appropriate interventions. Admission in children, not infants, was independently associated with RR, oxygen saturation, lobar CXR changes and pyrexia. Neither C-reactive protein, lobar CXR changes or pyrexia were associated with severity. Children over 1 year old with perihilar CXR changes more often had severe disease (p = 0.001). Initial intravenous antibiotics were associated with lobar CXR changes in infants and children and with dyspnoea, pyrexia and pleural effusion in children. The presence of pleural effusion increased duration of antibiotic treatment (p<0.001). Cefuroxime was the most often used intravenous antibiotic in 61%. Oral antibiotics included a penicillin in 258 (46%), a macrolide in 192 (34%) and a cephalosporin in 117 (21%). Infants stayed significantly longer (p<0.001) as did children with severe disease (p<0.01), effusions (p = 0.005) or lobar CXR changes (p< or =0.001).
CONCLUSIONS: There is a high rate of intravenous antibiotic administration in hospital admissions for pneumonia. Despite lobar CXR changes not being independently associated with severe disease, initial lobar CXR changes and clinical assessment in children independently influenced management decisions, including admission and route of antibiotics.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17261579      PMCID: PMC2083747          DOI: 10.1136/adc.2006.097402

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  27 in total

1.  British Thoracic Society Guidelines for the Management of Community Acquired Pneumonia in Childhood.

Authors: 
Journal:  Thorax       Date:  2002-05       Impact factor: 9.139

2.  Rationalised prescribing for community acquired pneumonia: a closed loop audit.

Authors:  H Clements; T Stephenson; V Gabriel; T Harrison; M Millar; A Smyth; W Tong; C J Linton
Journal:  Arch Dis Child       Date:  2000-10       Impact factor: 3.791

3.  Clinical predictors of hypoxaemia in children with pneumonia.

Authors:  A Smyth; H Carty; C A Hart
Journal:  Ann Trop Paediatr       Date:  1998-03

4.  A practical guide for the diagnosis and treatment of pediatric pneumonia.

Authors:  T Jadavji; B Law; M H Lebel; W A Kennedy; R Gold; E E Wang
Journal:  CMAJ       Date:  1997-03-01       Impact factor: 8.262

5.  Do published guidelines predict pneumonia in children presenting to an urban ED?

Authors:  S G Rothrock; S M Green; J M Fanelli; E Cruzen; K A Costanzo; J Pagane
Journal:  Pediatr Emerg Care       Date:  2001-08       Impact factor: 1.454

6.  Serum procalcitonin, C-reactive protein and interleukin-6 for distinguishing bacterial and viral pneumonia in children.

Authors:  P Toikka; K Irjala; T Juvén; R Virkki; J Mertsola; M Leinonen; O Ruuskanen
Journal:  Pediatr Infect Dis J       Date:  2000-07       Impact factor: 2.129

Review 7.  Defining pneumonia in critically ill infants and children.

Authors:  Joanne M Langley; John S Bradley
Journal:  Pediatr Crit Care Med       Date:  2005-05       Impact factor: 3.624

8.  Clinical features, aetiology and outcome of empyema in children in the north east of England.

Authors:  K M Eastham; R Freeman; A M Kearns; G Eltringham; J Clark; J Leeming; D A Spencer
Journal:  Thorax       Date:  2004-06       Impact factor: 9.139

9.  Can we predict which children with clinically suspected pneumonia will have the presence of focal infiltrates on chest radiographs?

Authors:  Tim Lynch; Robert Platt; Serge Gouin; Charles Larson; Yves Patenaude
Journal:  Pediatrics       Date:  2004-03       Impact factor: 7.124

10.  Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia.

Authors:  Steven B Black; Henry R Shinefield; Stella Ling; John Hansen; Bruce Fireman; David Spring; Jack Noyes; Edwin Lewis; Paula Ray; Janelle Lee; Jill Hackell
Journal:  Pediatr Infect Dis J       Date:  2002-09       Impact factor: 2.129

View more
  13 in total

1.  Validation of the British Thoracic Society Severity Criteria for Pediatric Community-acquired Pneumonia.

Authors:  Lilliam Ambroggio; Cole Brokamp; Rachel Mantyla; Bradley DePaoli; Richard M Ruddy; Samir S Shah; Todd A Florin
Journal:  Pediatr Infect Dis J       Date:  2019-09       Impact factor: 2.129

2.  The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America.

Authors:  John S Bradley; Carrie L Byington; Samir S Shah; Brian Alverson; Edward R Carter; Christopher Harrison; Sheldon L Kaplan; Sharon E Mace; George H McCracken; Matthew R Moore; Shawn D St Peter; Jana A Stockwell; Jack T Swanson
Journal:  Clin Infect Dis       Date:  2011-08-31       Impact factor: 9.079

3.  Are parents of children hospitalized with severe community-acquired pneumonia more satisfied with care when physicians allow them to share decisions on the antibiotic route?

Authors:  Paola Rosati; Viviana Di Salvo; Stefania Crudo; Roberto D'Amico; Cecilia Carlino; Maria Rosaria Marchili; Michaela Gonfiantini; Vincenzo Di Ciommo
Journal:  Health Expect       Date:  2014-04-28       Impact factor: 3.377

4.  Comparison of oral amoxicillin and intravenous benzyl penicillin for community acquired pneumonia in children (PIVOT trial): a multicentre pragmatic randomised controlled equivalence trial.

Authors:  Maria Atkinson; Monica Lakhanpaul; Alan Smyth; Harish Vyas; Vivienne Weston; Jabulani Sithole; Victoria Owen; Katharine Halliday; Helen Sammons; Jo Crane; Narayan Guntupalli; Lynda Walton; Titus Ninan; Anu Morjaria; Terence Stephenson
Journal:  Thorax       Date:  2007-06-13       Impact factor: 9.139

5.  When and how do GPs record vital signs in children with acute infections? A cross-sectional study.

Authors:  Claire Blacklock; Tanya Ali Haj-Hassan; Matthew J Thompson
Journal:  Br J Gen Pract       Date:  2012-10       Impact factor: 5.386

6.  Admission chest radiographs predict illness severity for children hospitalized with pneumonia.

Authors:  Lauren McClain; Matthew Hall; Samir S Shah; Joel S Tieder; Angela L Myers; Katherine Auger; Angela M Statile; Karen Jerardi; Mary Ann Queen; Evan Fieldston; Derek J Williams
Journal:  J Hosp Med       Date:  2014-06-18       Impact factor: 2.960

7.  Changing clinical practice: management of paediatric community-acquired pneumonia.

Authors:  Mohamed A Elemraid; Stephen P Rushton; Matthew F Thomas; David A Spencer; Katherine M Eastham; Andrew R Gennery; Julia E Clark
Journal:  J Eval Clin Pract       Date:  2013-10-07       Impact factor: 2.431

8.  High pneumonia lifetime-ever incidence in Beijing children compared with locations in other countries, and implications for national PCV and Hib vaccination.

Authors:  Fang Qu; Louise B Weschler; Yuexia Sun; Jan Sundell
Journal:  PLoS One       Date:  2017-02-06       Impact factor: 3.240

9.  Nutritional status of children hospitalized for parapneumonic effusion.

Authors:  Koen Huysentruyt; Philippe Alliet; Marc Raes; Julie Willekens; Iris De Schutter; Elke De Wachter; Anne Malfroot; Thierry Devreker; Philippe Goyens; Yvan Vandenplas; Jean De Schepper
Journal:  PLoS One       Date:  2014-04-04       Impact factor: 3.240

10.  Procalcitonin for Diagnostics and Treatment Decisions in Pediatric Lower Respiratory Tract Infections.

Authors:  Philipp Baumann; Gurli Baer; Jessica Bonhoeffer; Aline Fuchs; Verena Gotta; Ulrich Heininger; Nicole Ritz; Gabor Szinnai; Jan Bonhoeffer
Journal:  Front Pediatr       Date:  2017-08-28       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.